- What other names is Iboga known by?
- What is Iboga?
- How does Iboga work?
- Are there safety concerns?
- Are there any interactions with medications?
- Dosing considerations for Iboga.
Bois Sacré, Eboka, Tabernanthe iboga.
Iboga is a shrub. It is used for ritual and ceremonial purposes in some African cultures. The root bark of the plant is also used as medicine. Ibogaine is a chemical in iboga which is illegal in the United States.
People take iboga for fever, influenza (the flu), swine flu, high blood pressure, drug abuse, HIV/AIDS, and nerve disorders. They also take it for preventing fatigue and drowsiness, for increasing sex drive, for fighting substance abuse and addictions, and as a general tonic.
Insufficient Evidence to Rate Effectiveness for...
- Drug abuse. Early evidence suggests that ibogaine, a chemical in iboga, can help increase abstinence and relieve withdrawal symptoms in people abusing drugs such as heroin, codeine, cocaine and other substances such as alcohol, tobacco, and marijuana. However the existing research is flawed and unreliable.
- High blood pressure.
- Nerve disorders.
- Preventing fatigue and drowsiness.
- Other conditions.
Iboga contains chemicals that can cause brain stimulation.
Ibogaine, a chemical in iboga, is POSSIBLY SAFE when taken by mouth in smaller doses and under a health care professionals supervision. Due to potentially dangerous side effects it should not be used without advice of a medical practitioner.
There isn't enough information to know if iboga the shrub is safe to be used.
Special Precautions & Warnings:Pregnancy and breast-feeding: Not enough is known about the use of iboga during pregnancy and breast-feeding. Stay on the safe side and avoid use.
Paroxetine (Paxil)Interaction Rating: Major Do not take this combination.
Iboga contains ibogaine. Ibogaine is changed and broken down by the liver. Paroxetine can slow the liver from breaking down ibogaine. This might increase the chance of side effects caused by ibogaine.
Drying medications (Anticholinergic drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Iboga contains chemicals that can affect the brain and heart. Some drying medications called anticholinergic drugs can also affect the brain and heart. But iboga works differently than drying medications. Iboga might decrease the effects of drying medications.
Medications that can cause an irregular heartbeat (QT interval-prolonging drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Ibogaine, a chemical in iboga, can cause irregular heartbeat. Taking iboga along with medications that can cause an irregular heartbeat might cause serious side effects including heart attack and death.
Some medications that can cause an irregular heartbeat include amiodarone (Cordarone), disopyramide (Norpace), dofetilide (Tikosyn), ibutilide (Corvert), procainamide (Pronestyl), quinidine, sotalol (Betapace), thioridazine (Mellaril), and many others.
Medications that decrease breakdown of other medications by the liver (Cytochrome P450 2D6 (CYP2D6) inhibitors)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Iboga contains ibogaine. Ibogaine is changed and broken down by the liver. Some drugs can slow the liver from breaking down ibogaine. This might increase the chance of side effects caused by ibogaine. Some of these medications include amiodarone (Cordarone), amitriptyline (Elavil), cinacalcet (Sensipar), bupropion (Wellbutrin), dronedarone (Multaq), duloxetine (Cymbalta), fluoxetine (Prozac), darifenacin (Enablex), paroxetine (Paxil), quinidine (Quinidex), ritonavir (Norvir), sertraline (Zoloft), terbinafine (Lamisil), and others.
Various medications used for glaucoma, Alzheimer's disease, and other conditions (Cholinergic drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Iboga contains chemicals that affect the body. This chemical is similar to some medications used for glaucoma, Alzheimer's disease, and other conditions. Taking iboga with these medications might increase the chance of side effects.
The appropriate dose of iboga depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for iboga. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.
Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, and Insufficient Evidence to Rate (detailed description of each of the ratings).
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Health Solutions From Our Sponsors
: Lists of: Scheduling Actions Controlled Substances Regulated Chemicals. U.S. Department of Justice, Drug Enforcement Administration, Office of Diversion Control Drug & Chemical Evaluation Section, July 2015. Assessed August 3, 2015: http://www.deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf
Alper K, Reith ME, Sershen H. Ibogaine and the inhibition of acetylcholinesterase. J Ethnopharmacol. 2012;139(3):879-82. View abstract.
Alper KR, Lotsof HS, Frenken GM, et al. Treatment of acute opioid withdrawal with ibogaine. Am J Addict. 1999 Summer;8(3):234-42. View abstract.
Asua. Growing menace of ibogaine toxicity. Br J Anaesth. 2013;111(6):1029-30. View abstract.
Bruneton J. Pharmacognosy, Phytochemistry, Medicinal Plants. Paris: Lavoisier Publishing, 1995.
Glick SD, Maisonneuve IS. Mechanisms of antiaddictive actions of ibogaine. Ann N Y Acad Sci 1998;844:214-26. View abstract.
Glue P, Winter H, Garbe K, et al. Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20?mg dose of ibogaine in healthy volunteers. J Clin Pharmacol. 2015;55(6):680-7. View abstract.
Henstra M, Wong L, Chahbouni A, et al. Toxicokinetics of ibogaine and noribogaine in a patient with prolonged multiple cardiac arrhythmias after ingestion of internet purchased ibogaine. Clin Toxicol (Phila). 2017;55(6):600-602. View abstract.
Hoelen DW, Spiering W, Valk GD. Long-QT syndrome induced by the antiaddiction drug ibogaine. N Engl J Med. 2009;360(3):308-9. View abstract.
Jalal S, Daher E, Hilu R. A case of death due to ibogaine use for heroin addiction: case report. Am J Addict. 2013;22(3):302. View abstract.
Litjens RP, Brunt TM. How toxic is ibogaine? Clin Toxicol (Phila). 2016;54(4):297-302. View abstract.
Marta CJ, Ryan WC, Kopelowicz A, Koek RJ. Mania following use of ibogaine: A case series. Am J Addict. 2015;24(3):203-5. View abstract.
Mash DC, Kovera CA, Buck BE, et al. Medication development of ibogaine as a pharmacotherapy for drug dependence. Ann N Y Acad Sci 1998;844:274-92. View abstract.
Mazoyer C, Carlier J, Boucher A, Péoc'h M, Lemeur C, Gaillard Y. Fatal case of a 27-year-old male after taking iboga in withdrawal treatment: GC-MS/MS determination of ibogaine and ibogamine in iboga roots and postmortem biological material. J Forensic Sci. 2013;58(6):1666-72. View abstract.
O'Connell CW, Gerona RR, Friesen MW, Ly BT. Internet-purchased ibogaine toxicity confirmed with serum, urine, and product content levels. Am J Emerg Med. 2015; 33(7):985.e5-6. View abstract.
Paling FP, Andrews LM, Valk GD, Blom HJ. Life-threatening complications of ibogaine: three case reports. Neth J Med. 2012;70(9):422-4. View abstract.
Papadodima SA, Dona A, Evaggelakos CI, Goutas N, Athanaselis SA. Ibogaine related sudden death: a case report. J Forensic Leg Med. 2013;20(7):809-11. View abstract.
Pleskovic A, Gorjup V, Brvar M, Kozelj G. Ibogaine-associated ventricular tachyarrhythmias. Clin Toxicol (Phila). 2012;50(2):157. View abstract.
Schenberg EE, de Castro Comis MA, Chaves BR, da Silveira DX. Treating drug dependence with the aid of ibogaine: a retrospective study. J Psychopharmacol. 2014;28(11):993-1000. View abstract.
Sheppard SG. A preliminary investigation of ibogaine: case reports and recommendations for further study. J Subst Abuse Treat. 1994 Jul-Aug;11(4):379-85. View abstract.
Silva EM, Cirne-Santos CC, Frugulhetti IC, et al. Anti-HIV-1 activity of the Iboga alkaloid congener 18-methoxycoronaridine. Planta Med 2004;70:808-12. View abstract.
Vlaanderen L, Martial LC, Franssen EJ, van der Voort PH, Oosterwerff E, Somsen GA. Cardiac arrest after ibogaine ingestion. Clin Toxicol (Phila). 2014;52(6):642-3. View abstract.
Ward J, Rosenbaum C, Hernon C, McCurdy CR, Boyer EW. Herbal medicines for the management of opioid addiction: safe and effective alternatives to conventional pharmacotherapy? CNS Drugs 2011;25(12):999-1007. View abstract.